An­oth­er 4 phar­mas make the fa­bled Nas­daq leap, with com­bined raise rapid­ly ap­proach­ing $4.5B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

The IPO train is once again full-steam ahead with four new pric­ings an­nounced af­ter mar­ket close Thurs­day.

De­sign Ther­a­peu­tics, Edge­wise Ther­a­peu­tics, Ike­na On­col­o­gy and Uni­verse Phar­ma­ceu­ti­cals are all hit­ting Nas­daq on Fri­day. The for­mer three each hauled in more than $100 mil­lion, with De­sign rais­ing $240 mil­lion, Edge­wise net­ting $176 mil­lion and Ike­na pulling off a $125 mil­lion raise. Uni­verse clocked in at $25 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.